Ginkgo Bioworks DNA Contingent Consideration Liability (Non-Current)
Contingent Consideration Liability (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's contingent consideration liability (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's contingent consideration liability (non-current)?
- Ginkgo Bioworks (DNA) reported contingent consideration liability (non-current) of $252K in Q1 2026.
- How has Ginkgo Bioworks's contingent consideration liability (non-current) changed year-over-year?
- Ginkgo Bioworks's contingent consideration liability (non-current) decreased by 92.1% year-over-year, from $3.18M to $252K.
- What is the long-term trend for Ginkgo Bioworks's contingent consideration liability (non-current)?
- Over 3 years (2022 to 2025), Ginkgo Bioworks's contingent consideration liability (non-current) has grown at a -75.9% compound annual growth rate (CAGR), from $18.1M to $252K.